Results 141 to 150 of about 49,344 (290)
ABSTRACT Introduction Erythropoiesis‐stimulating agents (ESAs) and iron supplementation are standard treatments for chronic kidney disease (CKD)–related anemia. Targeting higher hemoglobin values in CKD increases cardiovascular risk. Whether the increased risk is from higher ESA doses or higher hemoglobin levels is uncertain, but alternative therapies ...
Alan Jardine +9 more
wiley +1 more source
Hypertension and its complications in a young man with autoimmune disease [PDF]
Basile, Jan N. +9 more
core +1 more source
In heart failure, renin‐angiotensin system inhibitor (RASI) use was associated with less skeletal muscle wasting in patients with diabetes, but not in those without diabetes (significant interaction). The association in diabetes was more evident at lower plasma 3‐methylhistidine levels than at higher levels, suggesting a potential biomarker‐defined ...
Hidemichi Kouzu +10 more
wiley +1 more source
Changes of Serum Potassium During Renal Homotransplantation [PDF]
Aldrete, JA, O'Higgins, JW, Starzl, TE
core +1 more source
Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
Samantha Hudzik +2 more
openalex +2 more sources
Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]
Atkins +46 more
core +2 more sources
The prevalence of RAASi uptitration limiting hyperkalemia and the suitability of potassium binders among patients suffering from heart failure with reduced ejection fraction [PDF]
Beáta Bódi +11 more
openalex +1 more source
Welfare Indicators for Aquaculture Research: Toolboxes for Five Farmed European Fish Species
ABSTRACT Refining approaches to measuring, monitoring and appraising animal welfare in aquaculture research is key to (i) protecting and optimizing it, (ii) documenting the severity of how and when it deviates, and (iii) ensuring good scientific quality, reliable results and reproducibility, amongst other factors.
Chris Noble +50 more
wiley +1 more source
Hyperkalemia Is an Underestimated Risk Factor in COPD
Jukka Mäenpää,1 Isobel Anderson,2 Caroline A Owen,3 Ulrika Emerath,1 Rod Hughes,4 Stefan R Sultana,5 Marita Olsson6 1Chief Medical Office, Research & Development, Patient Safety Biopharma, AstraZeneca, Gothenburg, Sweden; 2Patient Safety Operations ...
Mäenpää J +6 more
doaj

